Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Journal of Clinical Medicine|September 14, 2024
Investigation of Glucose Metabolism by Continuous Glucose Monitoring and Validation of Dipeptidyl Peptidase 4 Inhibitor Use in Patients with Myotonic Dystrophy Type 1Hiroto Takada, Tsuyoshi Matsumura, Haruna Shimamura, et al.Rinsho Shinkeigaku = Clinical Neurology|January 21, 2020
[Study of care practices for patients with myotonic dystrophy in Japan-Nationwide patient survey]Masanori P Takahashi, Risa Yamamoto, Tomoya Kubota, et al.Muscle & Nerve|January 26, 2019
The myotonic dystrophy health index: Japanese adaption and validity testingItsuki Mori, Haruo Fujino, Tsuyoshi Matsumura, et al.Journal of Neuromuscular Diseases|October 24, 2019
Caregiver Burden and Related Factors Among Caregivers of Patients with Myotonic Dystrophy Type 1Go Kurauchi, Makiko Endo, Kaori Odaira, et al.Disability and Rehabilitation|March 31, 2024
Facioscapulohumeral muscular dystrophy Health Index: Japanese translation and validation studyHaruo Fujino, Masanori P Takahashi, Harumasa Nakamura, et al.Neuropsychiatric Disease and Treatment|January 26, 2019
Health-related quality of life and its correlates in Japanese patients with myotonic dystrophy type 1Makiko Endo, Kaori Odaira, Ryohei Ono, et al.Neuromuscular Disorders : NMD|December 23, 2016
Study of Duchenne muscular dystrophy long-term survivors aged 40 years and older living in specialized institutions in JapanToshio Saito, Mitsuru Kawai, En Kimura, et al.Journal of Clinical Medicine|November 27, 2025
Plasma Neurofilament Light Chain and Phosphorylated Tau Are Elevated in Myotonic Dystrophy Type 1Masanori P Takahashi, Harutsugu Tatebe, Hiroto Takada, et al.Eclinicalmedicine|February 5, 2024
Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialMasayuki Nakamori, Daisaku Nakatani, Tomoharu Sato, et al.European Heart Journal Open|October 11, 2024
CTG repeat length underlying cardiac events and sudden death in myotonic dystrophy type 1Hideki Itoh, Takashi Hisamatsu, Kazuhiko Segawa, et al.Pageof 3